Which class of instrument the question needs before any cell analyzers shortlist is drawn: what a cell analyzer measures that a cell counter cannot, why a cell sorter, and the cell sorters a core facility runs, is a containment and biosafety purchase as much as an optical one, where a benchtop flow cytometer and a flow cytometer machine stop short of what sorting demands, what cell counting instruments settle quickly and cheaply, and how antigen density flow cytometry work sets the detector and fluorophore requirements that separate an adequate instrument from an expensive one
Three instrument classes get discussed as one. A counter tells you how many cells and how many are alive. An analyser tells you what they express, one cell at a time. A sorter physically separates them, and in doing so becomes a containment problem. Buying up the chain because it seems safer is how laboratories acquire instruments nobody is trained to run.
- the biosafety manual that decides containment for aerosol generating sorts
- BMBL
- the bloodborne pathogens standard, 29 CFR
- 1910.1030
- good laboratory practice for nonclinical studies, 21 CFR
- Part 58
The figures in this panel are regulation and manual identifiers, named from the documents themselves and linked below. They are not prices: BioBricks publishes verified prices for synthesis services only, and does not imply an instrument price index it has not measured.
- 4 vendor service pages verifiedevery figure matched verbatim to the vendor's page
- Quoted and dated, never estimatedlast verification pass 2026-08-24
- 1 service classes coveredeach with measured search demand behind it
Choosing the class and the configuration
- Decide whether cells must be recovered. If the experiment ends with a measurement, an analyser suffices. If it continues with the cells, you need a sorter, and that changes the room, the training, the maintenance and the cost by a large factor. This is the first question and it settles most of the decision.
- Count the parameters the panel genuinely needs. Detector count should follow from the panel design, including exclusions and viability, with a margin for the panel you will design next year. Buying maximum parameters for a four colour laboratory wastes money and adds spread.
- Match lasers to the fluorophores, not the other way round. The laser lines determine which dyes are excitable and how brightly. Check that the reagents your assays already depend on work well on the proposed configuration, because rebuilding validated panels around a new instrument is a hidden migration cost.
- Treat sorting as a biosafety project. Sorters generate aerosols. Handling human or infectious material on one requires containment appropriate to the agent, verified airflow, and a documented failure procedure. Involve the biosafety officer at specification, not at installation.
- Plan quality control from day one. Daily performance tracking with beads, recorded over time, is what tells you an instrument has drifted rather than the biology having changed. Instruments differ in how easy this is to run and to review, which matters more than a headline sensitivity figure.
- Budget the operator, not just the instrument. Analysers can be shared and largely self service; sorters realistically need a trained operator. If no such person exists and none is being hired, a sorting service is cheaper and gives better data than an underused instrument.
Sorting changes the room, not just the bench
A sorter breaks the sample into charged droplets, and droplets become aerosols. For human derived or infectious material that means containment appropriate to the agent, verified airflow, a defined response to a nozzle blockage and training that is documented rather than assumed.
Laboratories that buy a sorter without this in place either do not use it for the material they bought it for, or use it in a way that would not survive a safety review. Neither outcome justifies the purchase.
Rare events need a different specification
Detecting a population present at very low frequency is a problem of total events acquired, of dead cell and doublet exclusion, and of how cleanly the instrument handles carryover between samples. Sensitivity in the brochure sense is rarely the limitation.
If rare populations are the point, specify acquisition rate, carryover and the exclusion channels explicitly, and test on a spiked sample of your own during evaluation.
Common questions
- Can an analyser be upgraded to a sort?
- Generally no. Sorting requires fluidics, droplet formation and charging hardware that are designed in, and the containment requirements differ. Treat it as a different purchase rather than an option to add later.
- Is a benchtop instrument enough?
- For most immunophenotyping with moderate parameter counts, yes, and the simplicity is a real advantage in a shared laboratory. The limits appear with very large panels, rare event detection and any requirement to recover cells.
- When is a simple counter the right purchase?
- When the question is concentration and viability for seeding, passaging or dosing. Using a full analyser for that ties up an expensive instrument and produces no additional information.
- Should sorting be outsourced?
- Frequently yes, particularly where sorting is occasional. A core facility or a service brings a trained operator, maintained instruments and the containment already in place, and the per sample cost is usually below the true cost of owning one.
Get a shortlist for your project
Browse by service class
Sources
Cite or embed this figure
The median advertised gene synthesis price per base pair in the US research synthesis services market was $0.11 in August 2026, across 4 verified vendor service pages recorded in BioBricks Synthesis Price Index.
Cite as: "BioBricks Synthesis Price Index", updated 2026-08-24, https://biobricks.org/cell-analyzers/.